102 related articles for article (PubMed ID: 2086681)
1. Dapsone, folate synthesis and M. leprae.
Chatterjee BR
Indian J Lepr; 1990; 62(4):459-66. PubMed ID: 2086681
[No Abstract] [Full Text] [Related]
2. One-carbon requirements of Mycobacterium leprae: need for the folate pathway.
Wheeler PR
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):445-50. PubMed ID: 1474283
[No Abstract] [Full Text] [Related]
3. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
Seydel JK; Richter M; Wempe E
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
5. Mechansism of action of DDS.
Hasting RC
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):65. PubMed ID: 6988348
[No Abstract] [Full Text] [Related]
6. Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison.
Kulkarni VM; Seydel JK
Chemotherapy; 1983; 29(1):58-67. PubMed ID: 6339181
[TBL] [Abstract][Full Text] [Related]
7. The effect of dihydrofolate reductase inhibitors on Mycobacterium Leprae in the mouse foot pad.
Gelber RH; Levy L
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):124-32. PubMed ID: 776847
[No Abstract] [Full Text] [Related]
8. In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
Dhople AM
Int J Antimicrob Agents; 2002 Jan; 19(1):71-4. PubMed ID: 11814771
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
10. Dapsone susceptibility of M. leprae before and after 1977.
Almeida JG
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):726-7. PubMed ID: 3323374
[No Abstract] [Full Text] [Related]
11. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
12. Dapsone susceptibility of Mycobacterium leprae isolated before 1977.
Baohong J; de la Cruz EC; Levy L; Pattyn SR; Rees RJ
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):326-8. PubMed ID: 3045229
[No Abstract] [Full Text] [Related]
13. Grades of dapsone resistance to Mycobacterium leprae (burrowing terminology).
Roy RG
Lepr India; 1983 Jan; 55(1):179-80. PubMed ID: 6348411
[No Abstract] [Full Text] [Related]
14. The killing of Mycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin.
Gelber RH
Lepr Rev; 1986 Dec; 57(4):347-53. PubMed ID: 3540497
[No Abstract] [Full Text] [Related]
15. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
Millan J; Moulia-Pelat JP
Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
[No Abstract] [Full Text] [Related]
18. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
19. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
Browne SG
Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
[No Abstract] [Full Text] [Related]
20. Dapsone resistance in North India.
Sreevatsa ; Girdhar BK; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(3):514-8. PubMed ID: 3913706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
